Geza Acs

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. ncbi A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Mod Pathol 25:556-66. 2012
  2. ncbi The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Mod Pathol 25:163-77. 2012
  3. ncbi The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma
    Geza Acs
    Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Am J Surg Pathol 33:202-10. 2009
  4. ncbi The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
    Jennifer E Joh
    Department of Women s Oncology, Comprehensive Breast Program, H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Oncologist 16:1520-6. 2011
  5. ncbi Gene expression profiling in breast cancer
    Kiran Turaga
    Department of Women s Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 17:177-82. 2010
  6. ncbi High-risk benign breast lesions: current strategies in management
    John V Kiluk
    Comprehensive Breast Cancer Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 14:321-9. 2007
  7. ncbi Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor
    Marilyn M Bui
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Sarcoma 2011:971050. 2011

Collaborators

Detail Information

Publications7

  1. ncbi A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Mod Pathol 25:556-66. 2012
    ..Careful assessment and correlation with histopathological features in such cases may help in determining the appropriate patient management...
  2. ncbi The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Mod Pathol 25:163-77. 2012
    ....
  3. ncbi The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma
    Geza Acs
    Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Am J Surg Pathol 33:202-10. 2009
    ....
  4. ncbi The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
    Jennifer E Joh
    Department of Women s Oncology, Comprehensive Breast Program, H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Oncologist 16:1520-6. 2011
    ..This study has two primary endpoints: to evaluate the impact of Oncotype DX recurrence scores (RS) on chemotherapy recommendations and to compare the estimated recurrence risk predicted by breast oncology specialists to RS...
  5. ncbi Gene expression profiling in breast cancer
    Kiran Turaga
    Department of Women s Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 17:177-82. 2010
    ..This heterogeneity has spawned an era of molecular assays striving to classify and thus predict outcome, thereby guiding the future in targeted personalized treatment strategies...
  6. ncbi High-risk benign breast lesions: current strategies in management
    John V Kiluk
    Comprehensive Breast Cancer Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 14:321-9. 2007
    ..High-risk benign breast lesions can create confusion for both the patient and the clinician. This paper reviews the characteristics of these lesions to help direct appropriate management...
  7. ncbi Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor
    Marilyn M Bui
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Sarcoma 2011:971050. 2011
    ..Our results suggest a possible oncogenic and prognostic role for Cx43 and Cx26 in EWS/PNET. The lack of membranous immunoreactivity suggests that the effect of Cx in EWS/PNET is via a GJ function-independent mechanism...